BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2456919)

  • 1. (De)phosphorylation agents influence 5 alpha-reduction of testosterone in human prostate.
    Le Goff JM; Martin PM; Raynaud JP
    Endocrinology; 1988 Sep; 123(3):1693-5. PubMed ID: 2456919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
    Isaacs JT; Brendler CB; Walsh PC
    J Clin Endocrinol Metab; 1983 Jan; 56(1):139-46. PubMed ID: 6183287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone metabolism by homogenates of human prostates with benign hyperplasia: effects of zinc, cadmium and other bivalent cations.
    Sinquin G; Morfin RF; Charles JF; Floch HH
    J Steroid Biochem; 1984 Mar; 20(3):773-80. PubMed ID: 6200704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone 5 alpha-reductase and the accumulation of dihydrotestosterone in benign prostatic hyperplasia.
    Cowan RA; Cook B; Cowan SK; Grant JK; Sirett DA; Wallace AM
    J Steroid Biochem; 1979 Jul; 11(1B):609-13. PubMed ID: 90753
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of zinc on the 5 alpha-reduction of testosterone by the hyperplastic human prostate gland.
    Leake A; Chisholm GD; Habib FK
    J Steroid Biochem; 1984 Feb; 20(2):651-5. PubMed ID: 6200703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen metabolism in the epithelial and stromal components of the human hyperplastic prostate.
    Habib FK; Tesdale AL; Chisholm GD; Busuttil A
    J Endocrinol; 1981 Oct; 91(1):23-32. PubMed ID: 6170712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the nuclear 5 alpha-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia.
    Hudson RW; Wherrett D
    J Steroid Biochem; 1990 Feb; 35(2):231-6. PubMed ID: 1689784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of megestrol acetate (Megace) on steroid metabolism and steroid-protein binding in the human prostate.
    Geller J; Albert J; Geller S; Lopez D; Cantor T; Yen S
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1000-8. PubMed ID: 62759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
    Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
    Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
    Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
    J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-michaelian behavior of 5 alpha-reductase in human prostate.
    Le Goff JM; Martin PM; Ojasoo T; Raynaud JP
    J Steroid Biochem; 1989 Aug; 33(2):155-63. PubMed ID: 2475672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [5 alpha-reductase and prostate].
    Lobaccaro JM; Boudon C; Lumbroso S; Lechevallier E; Mottet N; Rebillard X; Sultan C
    Ann Endocrinol (Paris); 1997; 58(5):381-92. PubMed ID: 9685996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human prostatic cells in culture: different testosterone metabolic profile in epithelial cells and fibroblasts from normal or hyperplastic prostates.
    Berthaut I; Portois MC; Cussenot O; Mowszowicz I
    J Steroid Biochem Mol Biol; 1996 May; 58(2):235-42. PubMed ID: 8809206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural anti-androgen progesterone.
    Wright F; Kirchhoffer MO; Giacomini M
    Ann Endocrinol (Paris); 1979; 40(3 Suppl):282-93. PubMed ID: 496377
    [No Abstract]   [Full Text] [Related]  

  • 15. NAD(P)H-quinone oxidoreductase 1 silencing aggravates hormone-induced prostatic hyperplasia in mice.
    Kim HT; Kim YJ; Park SR; Ryu SY; Jung JY
    Andrologia; 2018 Apr; 50(3):. PubMed ID: 29110315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of steroidal and nonsteroidal estrogens on the 5 alpha-reduction of testosterone by the ventral prostate of the rat.
    Mäkelä S; Santti R; Martikainen P; Nienstedt W; Paranko J
    J Steroid Biochem; 1990 Feb; 35(2):249-56. PubMed ID: 2308339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
    Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
    J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human.
    Liang T; Cascieri MA; Cheung AH; Reynolds GF; Rasmusson GH
    Endocrinology; 1985 Aug; 117(2):571-9. PubMed ID: 4017948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine and cotinine effects on 3 alpha hydroxysteroid dehydrogenase in canine prostate.
    Meikle AW; Liu XH; Taylor GN; Stringham JD
    Life Sci; 1988; 43(23):1845-50. PubMed ID: 3200111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen metabolism in different target tissues.
    Martini L; Celotti F; Lechuga MJ; Melcangi RC; Motta M; Negri-Cesi P; Poletti A; Zoppi S
    Ann N Y Acad Sci; 1990; 595():184-98. PubMed ID: 1695827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.